Press Releases

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Trinity Biotech Announces Q3 2024 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Trinity Biotech Announces Q2 2024 Financial Results

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience